SZSE:002286 (China)
Â
(0 % min) Medium Term Notes 2005-15.3.17 Sr Series A Fltg Rt
Â¥
8.12
+0.32 (+4.1%)
Apr 25
What is a stock summary page? Click here for an overview.
Business Description
Baolingbao Biology Co Ltd
NAICS : 325411
SIC : 2833
ISIN : CNE100000FL1
Share Class Description:
SZSE:002286: (0 % min) Medium Term Notes 2005-15.3.17 Sr Series A Fltg RtCompare
Compare
Traded in other countries / regions
002286.China IPO Date
2009-08-28Description
Baolingbao Biology Co Ltd is engaged in providing biotechnology products and services. The products of the company include oligosaccharide, carbohydrate, sugar alcohol, dietary fiber, starch series, and syrup series.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.78 | |||||
| Equity-to-Asset | 0.76 | |||||
| Debt-to-Equity | 0.17 | |||||
| Debt-to-EBITDA | 2.48 | |||||
| Interest Coverage | 10.35 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 4.18 | |||||
| Beneish M-Score | -2.31 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 6.7 | |||||
| 3-Year EBITDA Growth Rate | 7.2 | |||||
| 3-Year EPS without NRI Growth Rate | -3.5 | |||||
| 3-Year FCF Growth Rate | -21.6 | |||||
| 3-Year Book Growth Rate | 7.3 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 67.33 | |||||
| 9-Day RSI | 58.58 | |||||
| 14-Day RSI | 55.9 | |||||
| 3-1 Month Momentum % | 4.18 | |||||
| 6-1 Month Momentum % | 11.31 | |||||
| 12-1 Month Momentum % | 36.47 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.46 | |||||
| Quick Ratio | 1 | |||||
| Cash Ratio | 0.47 | |||||
| Days Inventory | 50.71 | |||||
| Days Sales Outstanding | 39.2 | |||||
| Days Payable | 36.86 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.45 | |||||
| Dividend Payout Ratio | 0.36 | |||||
| 3-Year Dividend Growth Rate | 38.7 | |||||
| Forward Dividend Yield % | 1.47 | |||||
| 5-Year Yield-on-Cost % | 0.61 | |||||
| 3-Year Average Share Buyback Ratio | -0.1 | |||||
| Shareholder Yield % | 5.4 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 9.68 | |||||
| Operating Margin % | 5.91 | |||||
| Net Margin % | 4.56 | |||||
| FCF Margin % | 2.45 | |||||
| ROE % | 5.47 | |||||
| ROA % | 4.05 | |||||
| ROIC % | 5.45 | |||||
| 3-Year ROIIC % | 5.73 | |||||
| ROC (Joel Greenblatt) % | 8.34 | |||||
| ROCE % | 6.85 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 27.07 | |||||
| PE Ratio without NRI | 25.45 | |||||
| Shiller PE Ratio | 36.91 | |||||
| PEG Ratio | 2.6 | |||||
| PS Ratio | 1.21 | |||||
| PB Ratio | 1.48 | |||||
| Price-to-Tangible-Book | 1.57 | |||||
| Price-to-Free-Cash-Flow | 57.18 | |||||
| Price-to-Operating-Cash-Flow | 15.45 | |||||
| EV-to-EBIT | 20.8 | |||||
| EV-to-EBITDA | 20.8 | |||||
| EV-to-Revenue | 1.24 | |||||
| EV-to-FCF | 69.42 | |||||
| Price-to-GF-Value | 0.89 | |||||
| Price-to-Projected-FCF | 1.58 | |||||
| Price-to-DCF (Earnings Based) | 1.2 | |||||
| Price-to-DCF (FCF Based) | 4.95 | |||||
| Price-to-Median-PS-Value | 0.66 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.59 | |||||
| Price-to-Graham-Number | 1.33 | |||||
| Price-to-Net-Current-Asset-Value | 14 | |||||
| Earnings Yield (Greenblatt) % | 4.81 | |||||
| FCF Yield % | 1.38 | |||||
| Forward Rate of Return (Yacktman) % | 12.35 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Baolingbao Biology Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 2,401.755 | ||
| EPS (TTM) (Â¥) | 0.3 | ||
| Beta | 1.1 | ||
| 3-Year Sharpe Ratio | -0.44 | ||
| 3-Year Sortino Ratio | -0.58 | ||
| Volatility % | 31.47 | ||
| 14-Day RSI | 55.9 | ||
| 14-Day ATR (Â¥) | 0.395051 | ||
| 20-Day SMA (Â¥) | 7.7875 | ||
| 12-1 Month Momentum % | 36.47 | ||
| 52-Week Range (Â¥) | 5.16 - 8.68 | ||
| Shares Outstanding (Mil) | 369.77 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Baolingbao Biology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Baolingbao Biology Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Baolingbao Biology Co Ltd Frequently Asked Questions
What is Baolingbao Biology Co Ltd(SZSE:002286)'s stock price today?
The current price of SZSE:002286 is ¥8.12. The 52 week high of SZSE:002286 is ¥8.68 and 52 week low is ¥5.16.
When is next earnings date of Baolingbao Biology Co Ltd(SZSE:002286)?
The next earnings date of Baolingbao Biology Co Ltd(SZSE:002286) is .
Does Baolingbao Biology Co Ltd(SZSE:002286) pay dividends? If so, how much?
The Dividend Yield %  of Baolingbao Biology Co Ltd(SZSE:002286) is 0.45% (As of Today), Highest Dividend Payout Ratio of Baolingbao Biology Co Ltd(SZSE:002286) was 1.8. The lowest was 0.14. And the median was 0.52. The  Forward Dividend Yield % of Baolingbao Biology Co Ltd(SZSE:002286) is 1.47%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers